In this issue:
Low risk of late recurrence in disease-free TNBC survivors at 5 years
Do gut microbiota influence breast cancer risk?
AML or MDS risk after modern adjuvant chemotherapy in older patients
Radiation use among older women with early-stage disease
Histological subtype may affect response to endocrine therapy
Using artificial intelligence for making treatment decisions
High-intensity interval training reduces cancer-related fatigue
Consider phase I clinical trials for breast cancer patients
Duloxetine ameliorates AI-associated arthralgias
Germline BRCA mutation and outcome in young-onset disease
Please login below to download this issue (PDF)